nodes	percent_of_prediction	percent_of_DWPC	metapath
Fingolimod—CYP2E1—Dacarbazine—melanoma	0.117	0.348	CbGbCtD
Fingolimod—CYP3A4—Temozolomide—melanoma	0.0847	0.251	CbGbCtD
Fingolimod—CYP2D6—Vemurafenib—melanoma	0.073	0.216	CbGbCtD
Fingolimod—CYP3A4—Vemurafenib—melanoma	0.0464	0.138	CbGbCtD
Fingolimod—S1PR1—umbilical vein—melanoma	0.0299	0.221	CbGeAlD
Fingolimod—CYP3A4—Docetaxel—melanoma	0.0159	0.0472	CbGbCtD
Fingolimod—S1PR1—endothelium—melanoma	0.0142	0.105	CbGeAlD
Fingolimod—S1PR1—blood vessel—melanoma	0.0131	0.0965	CbGeAlD
Fingolimod—Death—Docetaxel—melanoma	0.00919	0.0652	CcSEcCtD
Fingolimod—S1PR5—skin of body—melanoma	0.00826	0.0609	CbGeAlD
Fingolimod—CYP4F2—mammalian vulva—melanoma	0.00706	0.0521	CbGeAlD
Fingolimod—SPHK1—retina—melanoma	0.00682	0.0503	CbGeAlD
Fingolimod—SPHK1—skin of body—melanoma	0.00598	0.0442	CbGeAlD
Fingolimod—SPHK1—mammalian vulva—melanoma	0.00546	0.0403	CbGeAlD
Fingolimod—S1PR5—head—melanoma	0.00539	0.0398	CbGeAlD
Fingolimod—CYP4F12—mammalian vulva—melanoma	0.00524	0.0387	CbGeAlD
Fingolimod—CYP4F2—head—melanoma	0.00505	0.0373	CbGeAlD
Fingolimod—S1PR4—lymph node—melanoma	0.00449	0.0331	CbGeAlD
Fingolimod—S1PR3—head—melanoma	0.00448	0.0331	CbGeAlD
Fingolimod—Traumatic liver injury—Temozolomide—melanoma	0.00428	0.0304	CcSEcCtD
Fingolimod—S1PR1—head—melanoma	0.00395	0.0291	CbGeAlD
Fingolimod—Gamma-glutamyltransferase increased—Vemurafenib—melanoma	0.00379	0.0269	CcSEcCtD
Fingolimod—S1PR5—lymph node—melanoma	0.00377	0.0278	CbGeAlD
Fingolimod—S1PR3—lymph node—melanoma	0.00313	0.0231	CbGeAlD
Fingolimod—Lymphopenia—Temozolomide—melanoma	0.00311	0.0221	CcSEcCtD
Fingolimod—Lower respiratory tract infection—Docetaxel—melanoma	0.0031	0.022	CcSEcCtD
Fingolimod—Cerebral haemorrhage—Carmustine—melanoma	0.00298	0.0211	CcSEcCtD
Fingolimod—Cerebral haemorrhage—Temozolomide—melanoma	0.00288	0.0204	CcSEcCtD
Fingolimod—S1PR1—lymph node—melanoma	0.00276	0.0204	CbGeAlD
Fingolimod—SPHK1—lymph node—melanoma	0.00273	0.0202	CbGeAlD
Fingolimod—Visual acuity reduced—Temozolomide—melanoma	0.00268	0.019	CcSEcCtD
Fingolimod—CYP4F12—lymph node—melanoma	0.00263	0.0194	CbGeAlD
Fingolimod—Herpes zoster—Temozolomide—melanoma	0.00212	0.015	CcSEcCtD
Fingolimod—Lymphopenia—Docetaxel—melanoma	0.00207	0.0147	CcSEcCtD
Fingolimod—Gamma-glutamyltransferase increased—Temozolomide—melanoma	0.00194	0.0137	CcSEcCtD
Fingolimod—Liver injury—Temozolomide—melanoma	0.00189	0.0134	CcSEcCtD
Fingolimod—Weight decreased—Vemurafenib—melanoma	0.00177	0.0126	CcSEcCtD
Fingolimod—Infestation NOS—Vemurafenib—melanoma	0.00174	0.0124	CcSEcCtD
Fingolimod—Infestation—Vemurafenib—melanoma	0.00174	0.0124	CcSEcCtD
Fingolimod—Hepatic enzyme increased—Temozolomide—melanoma	0.00168	0.012	CcSEcCtD
Fingolimod—Connective tissue disorder—Vemurafenib—melanoma	0.00154	0.0109	CcSEcCtD
Fingolimod—Eye disorder—Vemurafenib—melanoma	0.00146	0.0104	CcSEcCtD
Fingolimod—Cardiac disorder—Vemurafenib—melanoma	0.00145	0.0103	CcSEcCtD
Fingolimod—Angiopathy—Vemurafenib—melanoma	0.00142	0.0101	CcSEcCtD
Fingolimod—Mediastinal disorder—Vemurafenib—melanoma	0.00141	0.01	CcSEcCtD
Fingolimod—Cerebrovascular accident—Bleomycin—melanoma	0.0014	0.00993	CcSEcCtD
Fingolimod—Alopecia—Vemurafenib—melanoma	0.00138	0.00982	CcSEcCtD
Fingolimod—Eye pain—Carmustine—melanoma	0.00133	0.00941	CcSEcCtD
Fingolimod—Back pain—Vemurafenib—melanoma	0.00132	0.00936	CcSEcCtD
Fingolimod—Gastroenteritis—Temozolomide—melanoma	0.0013	0.00926	CcSEcCtD
Fingolimod—Eye pain—Temozolomide—melanoma	0.00128	0.00909	CcSEcCtD
Fingolimod—Cough—Vemurafenib—melanoma	0.00119	0.00844	CcSEcCtD
Fingolimod—Liver function test abnormal—Dactinomycin—melanoma	0.00118	0.00838	CcSEcCtD
Fingolimod—Unspecified disorder of skin and subcutaneous tissue—Vemurafenib—melanoma	0.00115	0.00818	CcSEcCtD
Fingolimod—Aspartate aminotransferase increased—Dactinomycin—melanoma	0.00115	0.00817	CcSEcCtD
Fingolimod—Infection—Vemurafenib—melanoma	0.0011	0.00784	CcSEcCtD
Fingolimod—Liver function test abnormal—Carmustine—melanoma	0.0011	0.00784	CcSEcCtD
Fingolimod—Nervous system disorder—Vemurafenib—melanoma	0.00109	0.00774	CcSEcCtD
Fingolimod—Skin disorder—Vemurafenib—melanoma	0.00108	0.00767	CcSEcCtD
Fingolimod—Weight decreased—Bleomycin—melanoma	0.00107	0.00761	CcSEcCtD
Fingolimod—Pneumonia—Bleomycin—melanoma	0.00106	0.00754	CcSEcCtD
Fingolimod—Aspartate aminotransferase increased—Temozolomide—melanoma	0.00104	0.00739	CcSEcCtD
Fingolimod—Hypotension—Vemurafenib—melanoma	0.00104	0.00738	CcSEcCtD
Fingolimod—Alanine aminotransferase increased—Temozolomide—melanoma	0.00102	0.00724	CcSEcCtD
Fingolimod—Pneumonia—Dactinomycin—melanoma	0.000991	0.00704	CcSEcCtD
Fingolimod—Bronchitis—Temozolomide—melanoma	0.000961	0.00682	CcSEcCtD
Fingolimod—Gastrointestinal disorder—Vemurafenib—melanoma	0.00096	0.00682	CcSEcCtD
Fingolimod—Fatigue—Vemurafenib—melanoma	0.000959	0.00681	CcSEcCtD
Fingolimod—Pneumonia—Carmustine—melanoma	0.000928	0.00658	CcSEcCtD
Fingolimod—Depression—Carmustine—melanoma	0.00092	0.00653	CcSEcCtD
Fingolimod—Weight decreased—Temozolomide—melanoma	0.000904	0.00642	CcSEcCtD
Fingolimod—Pneumonia—Temozolomide—melanoma	0.000896	0.00636	CcSEcCtD
Fingolimod—Infestation NOS—Temozolomide—melanoma	0.000891	0.00633	CcSEcCtD
Fingolimod—Infestation—Temozolomide—melanoma	0.000891	0.00633	CcSEcCtD
Fingolimod—Depression—Temozolomide—melanoma	0.000889	0.00631	CcSEcCtD
Fingolimod—Alopecia—Bleomycin—melanoma	0.000838	0.00595	CcSEcCtD
Fingolimod—Sinusitis—Temozolomide—melanoma	0.000836	0.00594	CcSEcCtD
Fingolimod—Connective tissue disorder—Carmustine—melanoma	0.000814	0.00577	CcSEcCtD
Fingolimod—Asthenia—Vemurafenib—melanoma	0.000798	0.00566	CcSEcCtD
Fingolimod—Pruritus—Vemurafenib—melanoma	0.000787	0.00559	CcSEcCtD
Fingolimod—Connective tissue disorder—Temozolomide—melanoma	0.000786	0.00558	CcSEcCtD
Fingolimod—Alopecia—Dactinomycin—melanoma	0.000782	0.00555	CcSEcCtD
Fingolimod—Eye disorder—Carmustine—melanoma	0.000774	0.00549	CcSEcCtD
Fingolimod—Diarrhoea—Vemurafenib—melanoma	0.000761	0.0054	CcSEcCtD
Fingolimod—Migraine—Docetaxel—melanoma	0.000757	0.00537	CcSEcCtD
Fingolimod—Eye disorder—Temozolomide—melanoma	0.000748	0.00531	CcSEcCtD
Fingolimod—Cardiac disorder—Temozolomide—melanoma	0.000743	0.00527	CcSEcCtD
Fingolimod—Leukopenia—Bleomycin—melanoma	0.000739	0.00525	CcSEcCtD
Fingolimod—Dizziness—Vemurafenib—melanoma	0.000735	0.00522	CcSEcCtD
Fingolimod—Alopecia—Carmustine—melanoma	0.000732	0.00519	CcSEcCtD
Fingolimod—Angiopathy—Temozolomide—melanoma	0.000726	0.00515	CcSEcCtD
Fingolimod—Mental disorder—Carmustine—melanoma	0.000725	0.00515	CcSEcCtD
Fingolimod—Mediastinal disorder—Temozolomide—melanoma	0.000721	0.00512	CcSEcCtD
Fingolimod—Cough—Bleomycin—melanoma	0.00072	0.00511	CcSEcCtD
Fingolimod—Liver function test abnormal—Docetaxel—melanoma	0.00071	0.00504	CcSEcCtD
Fingolimod—Alopecia—Temozolomide—melanoma	0.000707	0.00502	CcSEcCtD
Fingolimod—Mental disorder—Temozolomide—melanoma	0.000701	0.00498	CcSEcCtD
Fingolimod—Back pain—Carmustine—melanoma	0.000697	0.00495	CcSEcCtD
Fingolimod—Headache—Vemurafenib—melanoma	0.000697	0.00495	CcSEcCtD
Fingolimod—Aspartate aminotransferase increased—Docetaxel—melanoma	0.000693	0.00492	CcSEcCtD
Fingolimod—Leukopenia—Dactinomycin—melanoma	0.000689	0.00489	CcSEcCtD
Fingolimod—Vision blurred—Carmustine—melanoma	0.000679	0.00482	CcSEcCtD
Fingolimod—Alanine aminotransferase increased—Docetaxel—melanoma	0.000678	0.00481	CcSEcCtD
Fingolimod—Back pain—Temozolomide—melanoma	0.000674	0.00478	CcSEcCtD
Fingolimod—Infection—Bleomycin—melanoma	0.000669	0.00475	CcSEcCtD
Fingolimod—Vision blurred—Temozolomide—melanoma	0.000656	0.00466	CcSEcCtD
Fingolimod—Leukopenia—Carmustine—melanoma	0.000645	0.00458	CcSEcCtD
Fingolimod—CYP2E1—head—melanoma	0.000633	0.00467	CbGeAlD
Fingolimod—Hypotension—Bleomycin—melanoma	0.00063	0.00447	CcSEcCtD
Fingolimod—Infection—Dactinomycin—melanoma	0.000624	0.00443	CcSEcCtD
Fingolimod—Leukopenia—Temozolomide—melanoma	0.000623	0.00443	CcSEcCtD
Fingolimod—Hypertension—Carmustine—melanoma	0.000622	0.00442	CcSEcCtD
Fingolimod—Palpitations—Temozolomide—melanoma	0.000615	0.00437	CcSEcCtD
Fingolimod—Cough—Temozolomide—melanoma	0.000608	0.00431	CcSEcCtD
Fingolimod—Paraesthesia—Bleomycin—melanoma	0.000605	0.00429	CcSEcCtD
Fingolimod—Weight decreased—Docetaxel—melanoma	0.000601	0.00427	CcSEcCtD
Fingolimod—Hypertension—Temozolomide—melanoma	0.000601	0.00427	CcSEcCtD
Fingolimod—Dyspnoea—Bleomycin—melanoma	0.000601	0.00426	CcSEcCtD
Fingolimod—Pneumonia—Docetaxel—melanoma	0.000596	0.00423	CcSEcCtD
Fingolimod—Infestation NOS—Docetaxel—melanoma	0.000593	0.00421	CcSEcCtD
Fingolimod—Infestation—Docetaxel—melanoma	0.000593	0.00421	CcSEcCtD
Fingolimod—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.000589	0.00418	CcSEcCtD
Fingolimod—Infection—Carmustine—melanoma	0.000584	0.00415	CcSEcCtD
Fingolimod—Infection—Temozolomide—melanoma	0.000565	0.00401	CcSEcCtD
Fingolimod—Nervous system disorder—Temozolomide—melanoma	0.000557	0.00396	CcSEcCtD
Fingolimod—Skin disorder—Temozolomide—melanoma	0.000552	0.00392	CcSEcCtD
Fingolimod—Hypotension—Carmustine—melanoma	0.00055	0.0039	CcSEcCtD
Fingolimod—Fatigue—Dactinomycin—melanoma	0.000542	0.00385	CcSEcCtD
Fingolimod—Paraesthesia—Carmustine—melanoma	0.000528	0.00375	CcSEcCtD
Fingolimod—Dyspnoea—Carmustine—melanoma	0.000524	0.00372	CcSEcCtD
Fingolimod—Connective tissue disorder—Docetaxel—melanoma	0.000523	0.00371	CcSEcCtD
Fingolimod—Paraesthesia—Temozolomide—melanoma	0.00051	0.00362	CcSEcCtD
Fingolimod—Gastrointestinal disorder—Carmustine—melanoma	0.000508	0.0036	CcSEcCtD
Fingolimod—Dyspnoea—Temozolomide—melanoma	0.000507	0.0036	CcSEcCtD
Fingolimod—CYP2D6—head—melanoma	0.000501	0.0037	CbGeAlD
Fingolimod—Eye disorder—Docetaxel—melanoma	0.000497	0.00353	CcSEcCtD
Fingolimod—Cardiac disorder—Docetaxel—melanoma	0.000494	0.00351	CcSEcCtD
Fingolimod—Gastrointestinal disorder—Temozolomide—melanoma	0.000491	0.00348	CcSEcCtD
Fingolimod—Fatigue—Temozolomide—melanoma	0.00049	0.00348	CcSEcCtD
Fingolimod—Asthenia—Bleomycin—melanoma	0.000483	0.00343	CcSEcCtD
Fingolimod—Angiopathy—Docetaxel—melanoma	0.000483	0.00343	CcSEcCtD
Fingolimod—Mediastinal disorder—Docetaxel—melanoma	0.00048	0.0034	CcSEcCtD
Fingolimod—Pruritus—Bleomycin—melanoma	0.000477	0.00338	CcSEcCtD
Fingolimod—Alopecia—Docetaxel—melanoma	0.00047	0.00334	CcSEcCtD
Fingolimod—Mental disorder—Docetaxel—melanoma	0.000466	0.00331	CcSEcCtD
Fingolimod—Asthenia—Dactinomycin—melanoma	0.000451	0.0032	CcSEcCtD
Fingolimod—Back pain—Docetaxel—melanoma	0.000448	0.00318	CcSEcCtD
Fingolimod—Diarrhoea—Dactinomycin—melanoma	0.00043	0.00305	CcSEcCtD
Fingolimod—Asthenia—Carmustine—melanoma	0.000422	0.003	CcSEcCtD
Fingolimod—Leukopenia—Docetaxel—melanoma	0.000415	0.00294	CcSEcCtD
Fingolimod—Palpitations—Docetaxel—melanoma	0.000409	0.00291	CcSEcCtD
Fingolimod—Asthenia—Temozolomide—melanoma	0.000408	0.00289	CcSEcCtD
Fingolimod—Cough—Docetaxel—melanoma	0.000404	0.00287	CcSEcCtD
Fingolimod—Diarrhoea—Carmustine—melanoma	0.000402	0.00286	CcSEcCtD
Fingolimod—Pruritus—Temozolomide—melanoma	0.000402	0.00285	CcSEcCtD
Fingolimod—Hypertension—Docetaxel—melanoma	0.0004	0.00284	CcSEcCtD
Fingolimod—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	0.000392	0.00278	CcSEcCtD
Fingolimod—Dizziness—Carmustine—melanoma	0.000389	0.00276	CcSEcCtD
Fingolimod—Diarrhoea—Temozolomide—melanoma	0.000389	0.00276	CcSEcCtD
Fingolimod—Dizziness—Temozolomide—melanoma	0.000376	0.00267	CcSEcCtD
Fingolimod—Infection—Docetaxel—melanoma	0.000376	0.00267	CcSEcCtD
Fingolimod—Nervous system disorder—Docetaxel—melanoma	0.000371	0.00263	CcSEcCtD
Fingolimod—Headache—Carmustine—melanoma	0.000368	0.00262	CcSEcCtD
Fingolimod—Skin disorder—Docetaxel—melanoma	0.000367	0.00261	CcSEcCtD
Fingolimod—Headache—Temozolomide—melanoma	0.000356	0.00253	CcSEcCtD
Fingolimod—Hypotension—Docetaxel—melanoma	0.000353	0.00251	CcSEcCtD
Fingolimod—Paraesthesia—Docetaxel—melanoma	0.000339	0.00241	CcSEcCtD
Fingolimod—Dyspnoea—Docetaxel—melanoma	0.000337	0.00239	CcSEcCtD
Fingolimod—Gastrointestinal disorder—Docetaxel—melanoma	0.000326	0.00232	CcSEcCtD
Fingolimod—Fatigue—Docetaxel—melanoma	0.000326	0.00231	CcSEcCtD
Fingolimod—Asthenia—Docetaxel—melanoma	0.000271	0.00193	CcSEcCtD
Fingolimod—Pruritus—Docetaxel—melanoma	0.000267	0.0019	CcSEcCtD
Fingolimod—Diarrhoea—Docetaxel—melanoma	0.000259	0.00184	CcSEcCtD
Fingolimod—Dizziness—Docetaxel—melanoma	0.00025	0.00177	CcSEcCtD
Fingolimod—Headache—Docetaxel—melanoma	0.000237	0.00168	CcSEcCtD
Fingolimod—CYP2D6—Metabolism—ACER3—melanoma	3.34e-05	8.63e-05	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—CASP3—melanoma	3.32e-05	8.6e-05	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—HRAS—melanoma	3.32e-05	8.59e-05	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—HRAS—melanoma	3.32e-05	8.59e-05	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—IL2—melanoma	3.32e-05	8.59e-05	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—PTGS2—melanoma	3.31e-05	8.57e-05	CbGpPWpGaD
Fingolimod—S1PR4—Signaling by GPCR—IL6—melanoma	3.3e-05	8.54e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Biological oxidations—CYP1B1—melanoma	3.27e-05	8.47e-05	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—CDKN1B—melanoma	3.26e-05	8.45e-05	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—CDKN1B—melanoma	3.26e-05	8.45e-05	CbGpPWpGaD
Fingolimod—S1PR1—Signaling by GPCR—PIK3CA—melanoma	3.26e-05	8.43e-05	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—MDM2—melanoma	3.24e-05	8.4e-05	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—CCND1—melanoma	3.23e-05	8.37e-05	CbGpPWpGaD
Fingolimod—S1PR5—GPCR downstream signaling—AKT1—melanoma	3.23e-05	8.35e-05	CbGpPWpGaD
Fingolimod—S1PR3—GPCR downstream signaling—AKT1—melanoma	3.23e-05	8.35e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metapathway biotransformation—CYP1B1—melanoma	3.23e-05	8.35e-05	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—MAP2K1—melanoma	3.23e-05	8.35e-05	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—PIK3CD—melanoma	3.21e-05	8.3e-05	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—CTNNB1—melanoma	3.2e-05	8.29e-05	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—ERBB2—melanoma	3.2e-05	8.28e-05	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—CASP3—melanoma	3.2e-05	8.28e-05	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—CASP3—melanoma	3.2e-05	8.28e-05	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—IL2—melanoma	3.19e-05	8.26e-05	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—IL2—melanoma	3.19e-05	8.26e-05	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—IL6—melanoma	3.18e-05	8.22e-05	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—IL6—melanoma	3.18e-05	8.22e-05	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—PIK3CB—melanoma	3.16e-05	8.17e-05	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—MMP9—melanoma	3.14e-05	8.13e-05	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—CDKN1A—melanoma	3.13e-05	8.1e-05	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—PTEN—melanoma	3.12e-05	8.08e-05	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—CCND1—melanoma	3.11e-05	8.06e-05	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—CCND1—melanoma	3.11e-05	8.06e-05	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—NFKB1—melanoma	3.11e-05	8.04e-05	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—CTNNB1—melanoma	3.08e-05	7.98e-05	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—CTNNB1—melanoma	3.08e-05	7.98e-05	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—FGF2—melanoma	3.07e-05	7.94e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—UGT2B10—melanoma	3.05e-05	7.9e-05	CbGpPWpGaD
Fingolimod—S1PR4—Signaling by GPCR—AKT1—melanoma	3.04e-05	7.88e-05	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—CXCL8—melanoma	3.03e-05	7.85e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—PLCB4—melanoma	3.03e-05	7.84e-05	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—MMP9—melanoma	3.02e-05	7.82e-05	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—MMP9—melanoma	3.02e-05	7.82e-05	CbGpPWpGaD
Fingolimod—S1PR1—Signaling by GPCR—HRAS—melanoma	3.01e-05	7.8e-05	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—CDKN1A—melanoma	3.01e-05	7.79e-05	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—CDKN1A—melanoma	3.01e-05	7.79e-05	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—PTEN—melanoma	3e-05	7.78e-05	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—PTEN—melanoma	3e-05	7.78e-05	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—NFKB1—melanoma	2.99e-05	7.74e-05	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—NFKB1—melanoma	2.99e-05	7.74e-05	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—CDKN1B—melanoma	2.96e-05	7.67e-05	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—AKT1—melanoma	2.93e-05	7.59e-05	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—AKT1—melanoma	2.93e-05	7.59e-05	CbGpPWpGaD
Fingolimod—S1PR1—GPCR downstream signaling—AKT1—melanoma	2.93e-05	7.59e-05	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—CASP3—melanoma	2.9e-05	7.52e-05	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—IL2—melanoma	2.9e-05	7.5e-05	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—PTEN—melanoma	2.89e-05	7.47e-05	CbGpPWpGaD
Fingolimod—S1PR1—Signaling by GPCR—IL6—melanoma	2.88e-05	7.47e-05	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—MDM2—melanoma	2.87e-05	7.43e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—SLC6A11—melanoma	2.85e-05	7.37e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—PIP4K2A—melanoma	2.85e-05	7.37e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—HS3ST5—melanoma	2.84e-05	7.34e-05	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—ERBB2—melanoma	2.83e-05	7.33e-05	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—CCND1—melanoma	2.83e-05	7.32e-05	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—VEGFA—melanoma	2.82e-05	7.3e-05	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—CTNNB1—melanoma	2.8e-05	7.24e-05	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—PIK3CB—melanoma	2.79e-05	7.23e-05	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—STAT3—melanoma	2.79e-05	7.22e-05	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—NRAS—melanoma	2.78e-05	7.21e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—MTAP—melanoma	2.77e-05	7.17e-05	CbGpPWpGaD
Fingolimod—CYP4F12—Metabolism—PIK3CA—melanoma	2.75e-05	7.11e-05	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—MMP9—melanoma	2.74e-05	7.1e-05	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—CDKN1A—melanoma	2.73e-05	7.08e-05	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—PTEN—melanoma	2.73e-05	7.06e-05	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—NFKB1—melanoma	2.71e-05	7.03e-05	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—VEGFA—melanoma	2.71e-05	7.02e-05	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—VEGFA—melanoma	2.71e-05	7.02e-05	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—STAT3—melanoma	2.69e-05	6.95e-05	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—STAT3—melanoma	2.69e-05	6.95e-05	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—CXCL8—melanoma	2.68e-05	6.95e-05	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—NRAS—melanoma	2.68e-05	6.94e-05	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—NRAS—melanoma	2.68e-05	6.94e-05	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—MAPK3—melanoma	2.67e-05	6.9e-05	CbGpPWpGaD
Fingolimod—S1PR1—Signaling by GPCR—AKT1—melanoma	2.66e-05	6.89e-05	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—CDKN1B—melanoma	2.62e-05	6.79e-05	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—MYC—melanoma	2.59e-05	6.71e-05	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—CASP3—melanoma	2.57e-05	6.65e-05	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—MAPK3—melanoma	2.57e-05	6.64e-05	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—MAPK3—melanoma	2.57e-05	6.64e-05	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—IL2—melanoma	2.57e-05	6.64e-05	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—MAPK1—melanoma	2.54e-05	6.57e-05	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—EGFR—melanoma	2.54e-05	6.57e-05	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—CCND1—melanoma	2.5e-05	6.47e-05	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—MYC—melanoma	2.5e-05	6.46e-05	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—MYC—melanoma	2.5e-05	6.46e-05	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—CTNNB1—melanoma	2.48e-05	6.41e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—LUM—melanoma	2.47e-05	6.39e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—PHGDH—melanoma	2.47e-05	6.39e-05	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—VEGFA—melanoma	2.46e-05	6.38e-05	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—MAPK1—melanoma	2.44e-05	6.32e-05	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—MAPK1—melanoma	2.44e-05	6.32e-05	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—EGFR—melanoma	2.44e-05	6.32e-05	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—EGFR—melanoma	2.44e-05	6.32e-05	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—STAT3—melanoma	2.44e-05	6.31e-05	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—NRAS—melanoma	2.43e-05	6.3e-05	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—MMP9—melanoma	2.43e-05	6.29e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—HPSE—melanoma	2.42e-05	6.27e-05	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—CDKN1A—melanoma	2.42e-05	6.26e-05	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—PTEN—melanoma	2.41e-05	6.25e-05	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—NFKB1—melanoma	2.4e-05	6.22e-05	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—KRAS—melanoma	2.4e-05	6.2e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—CUBN—melanoma	2.38e-05	6.15e-05	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism—PIK3CA—melanoma	2.37e-05	6.14e-05	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—MAPK3—melanoma	2.33e-05	6.03e-05	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—KRAS—melanoma	2.31e-05	5.97e-05	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—KRAS—melanoma	2.31e-05	5.97e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—CSPG4—melanoma	2.3e-05	5.94e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—BSG—melanoma	2.3e-05	5.94e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—SDHD—melanoma	2.3e-05	5.94e-05	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—MYC—melanoma	2.27e-05	5.87e-05	CbGpPWpGaD
Fingolimod—CYP4F12—Metabolism—AKT1—melanoma	2.24e-05	5.81e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—GPAM—melanoma	2.22e-05	5.75e-05	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—MAPK1—melanoma	2.22e-05	5.74e-05	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—EGFR—melanoma	2.22e-05	5.74e-05	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—PIK3CA—melanoma	2.2e-05	5.7e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—ACER3—melanoma	2.18e-05	5.65e-05	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—VEGFA—melanoma	2.18e-05	5.64e-05	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—STAT3—melanoma	2.16e-05	5.59e-05	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—NRAS—melanoma	2.15e-05	5.58e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—PLCB4—melanoma	2.15e-05	5.56e-05	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—TP53—melanoma	2.13e-05	5.51e-05	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—PIK3CA—melanoma	2.12e-05	5.49e-05	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—PIK3CA—melanoma	2.12e-05	5.49e-05	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—KRAS—melanoma	2.09e-05	5.42e-05	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—MAPK3—melanoma	2.06e-05	5.34e-05	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—TP53—melanoma	2.05e-05	5.31e-05	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—TP53—melanoma	2.05e-05	5.31e-05	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—HRAS—melanoma	2.04e-05	5.27e-05	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—PIK3CA—melanoma	2.04e-05	5.27e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—SLC6A11—melanoma	2.02e-05	5.23e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—PIP4K2A—melanoma	2.02e-05	5.23e-05	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—MYC—melanoma	2.01e-05	5.19e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—UGT2B10—melanoma	1.99e-05	5.16e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—MTAP—melanoma	1.97e-05	5.09e-05	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—MAPK1—melanoma	1.96e-05	5.08e-05	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—EGFR—melanoma	1.96e-05	5.08e-05	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—HRAS—melanoma	1.96e-05	5.08e-05	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—HRAS—melanoma	1.96e-05	5.08e-05	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—IL6—melanoma	1.95e-05	5.05e-05	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism—AKT1—melanoma	1.94e-05	5.01e-05	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—PIK3CA—melanoma	1.92e-05	4.98e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—PLA2G6—melanoma	1.89e-05	4.89e-05	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—IL6—melanoma	1.88e-05	4.86e-05	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—IL6—melanoma	1.88e-05	4.86e-05	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—TP53—melanoma	1.86e-05	4.82e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—HS3ST5—melanoma	1.85e-05	4.8e-05	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—KRAS—melanoma	1.85e-05	4.8e-05	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—AKT1—melanoma	1.8e-05	4.66e-05	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—HRAS—melanoma	1.78e-05	4.61e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—PHGDH—melanoma	1.75e-05	4.54e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—LUM—melanoma	1.75e-05	4.54e-05	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—AKT1—melanoma	1.73e-05	4.48e-05	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—AKT1—melanoma	1.73e-05	4.48e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—HPSE—melanoma	1.72e-05	4.45e-05	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—IL6—melanoma	1.7e-05	4.41e-05	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—PIK3CA—melanoma	1.7e-05	4.41e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—VCAN—melanoma	1.7e-05	4.4e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—CUBN—melanoma	1.69e-05	4.37e-05	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—AKT1—melanoma	1.66e-05	4.31e-05	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—TP53—melanoma	1.65e-05	4.26e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—CSPG4—melanoma	1.63e-05	4.22e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—BSG—melanoma	1.63e-05	4.22e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—SDHD—melanoma	1.63e-05	4.22e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—GPAM—melanoma	1.58e-05	4.08e-05	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—HRAS—melanoma	1.58e-05	4.08e-05	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—AKT1—melanoma	1.57e-05	4.07e-05	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—IL6—melanoma	1.51e-05	3.9e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—CYP17A1—melanoma	1.43e-05	3.71e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—PLCB4—melanoma	1.41e-05	3.64e-05	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—AKT1—melanoma	1.39e-05	3.6e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—GNA11—melanoma	1.35e-05	3.5e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—PLA2G6—melanoma	1.34e-05	3.47e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—FASN—melanoma	1.32e-05	3.43e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—PIP4K2A—melanoma	1.32e-05	3.42e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—SLC6A11—melanoma	1.32e-05	3.42e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—SLC5A5—melanoma	1.3e-05	3.37e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—MTAP—melanoma	1.29e-05	3.33e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—CD44—melanoma	1.26e-05	3.26e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—GNAQ—melanoma	1.26e-05	3.26e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—CYP1B1—melanoma	1.21e-05	3.12e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—VCAN—melanoma	1.2e-05	3.12e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—LUM—melanoma	1.15e-05	2.97e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—PHGDH—melanoma	1.15e-05	2.97e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—HPSE—melanoma	1.12e-05	2.91e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—CUBN—melanoma	1.1e-05	2.85e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—SDHD—melanoma	1.07e-05	2.76e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—BSG—melanoma	1.07e-05	2.76e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—CSPG4—melanoma	1.07e-05	2.76e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—GPAM—melanoma	1.03e-05	2.67e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—CYP17A1—melanoma	1.02e-05	2.63e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—ABCB1—melanoma	9.93e-06	2.57e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—GNA11—melanoma	9.6e-06	2.49e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—FASN—melanoma	9.4e-06	2.43e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—SLC5A5—melanoma	9.24e-06	2.39e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—PRKCA—melanoma	9.14e-06	2.37e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—ERCC2—melanoma	9.06e-06	2.35e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—GNAQ—melanoma	8.93e-06	2.31e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—CD44—melanoma	8.93e-06	2.31e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—PLA2G6—melanoma	8.77e-06	2.27e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—CYP1B1—melanoma	8.56e-06	2.22e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—VCAN—melanoma	7.88e-06	2.04e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—PIK3CG—melanoma	7.16e-06	1.85e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—ABCB1—melanoma	7.05e-06	1.82e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—PPARG—melanoma	6.91e-06	1.79e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—CYP17A1—melanoma	6.65e-06	1.72e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—PRKCA—melanoma	6.49e-06	1.68e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—ERCC2—melanoma	6.43e-06	1.66e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—PIK3CD—melanoma	6.29e-06	1.63e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—GNA11—melanoma	6.28e-06	1.62e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—ALB—melanoma	6.21e-06	1.61e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—FASN—melanoma	6.14e-06	1.59e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—SLC5A5—melanoma	6.04e-06	1.56e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—GNAQ—melanoma	5.84e-06	1.51e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—CD44—melanoma	5.84e-06	1.51e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—CYP1B1—melanoma	5.59e-06	1.45e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—PIK3CB—melanoma	5.49e-06	1.42e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—PTGS2—melanoma	5.43e-06	1.41e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—PIK3CG—melanoma	5.08e-06	1.31e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—PPARG—melanoma	4.9e-06	1.27e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—PTEN—melanoma	4.74e-06	1.23e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—ABCB1—melanoma	4.61e-06	1.19e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—PIK3CD—melanoma	4.47e-06	1.16e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—ALB—melanoma	4.41e-06	1.14e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—PRKCA—melanoma	4.24e-06	1.1e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—ERCC2—melanoma	4.21e-06	1.09e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—PIK3CB—melanoma	3.89e-06	1.01e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—PTGS2—melanoma	3.86e-06	9.98e-06	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—PTEN—melanoma	3.36e-06	8.71e-06	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—PIK3CA—melanoma	3.34e-06	8.66e-06	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—PIK3CG—melanoma	3.32e-06	8.6e-06	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—PPARG—melanoma	3.21e-06	8.3e-06	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—PIK3CD—melanoma	2.92e-06	7.56e-06	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—ALB—melanoma	2.88e-06	7.46e-06	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—AKT1—melanoma	2.73e-06	7.07e-06	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—PIK3CB—melanoma	2.54e-06	6.59e-06	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—PTGS2—melanoma	2.52e-06	6.53e-06	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—PIK3CA—melanoma	2.37e-06	6.14e-06	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—PTEN—melanoma	2.2e-06	5.69e-06	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—AKT1—melanoma	1.94e-06	5.02e-06	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—PIK3CA—melanoma	1.55e-06	4.02e-06	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—AKT1—melanoma	1.27e-06	3.28e-06	CbGpPWpGaD
